Morgan Stanley initiates Azzas 2154 stock with Overweight rating

Morgan Stanley initiated Overweight coverage on Azzas 2154 SA (AZZA3:BZ) with a R$56.00 price target, citing underappreciated earnings potential. The firm's 2026 and 2027 adjusted EBITDA estimates are 4% and 6% above consensus, respectively, as it believes the market is overly conservative on the combined operations following the 2024 merger that created Latin America's largest fashion brand platform. Despite initial management attrition, Morgan Stanley expects further upside as Azzas captures deal synergies, arguing the current ~8x 2026 P/E valuation reflects excessive market skepticism regarding these benefits.

Analysis

Morgan Stanley has initiated coverage on Azzas 2154 SA (AZZA3:BZ) with an Overweight rating and a R$56.00 price target, signaling a bullish outlook on the newly formed entity. The firm's core thesis is that the market is underappreciating the earnings potential following the 2024 merger of Arezzo & Co and Grupo Soma. This view is supported by Morgan Stanley's adjusted EBITDA estimates, which stand 4% above consensus for 2026 and 6% higher for 2027. The report attributes current market skepticism, reflected in a valuation of approximately 8x the 2026 P/E ratio, to early management attrition post-merger. However, Morgan Stanley contends that the organizational structure is now better positioned and that significant upside remains from deal synergies, which are not fully priced into the stock. The fact that consensus 2026 EBITDA estimates have already increased by 2% since the merger's conclusion may indicate the beginning of a positive revision cycle, lending credibility to the bank's optimistic stance.

Key Decisions for Investors

• Investors may consider initiating or adding to positions in Azzas 2154 SA, aligning with Morgan Stanley's thesis that the market is excessively discounting the potential for earnings growth and merger synergies.
• Monitor the company's quarterly reports for concrete evidence of synergy realization and margin improvements, as these will be the key catalysts to validate the Overweight thesis and drive a potential re-rating of the stock.
• Pay close attention to management stability and execution, as the initial post-merger attrition was a primary source of market concern, and continued effective leadership is critical to capturing the projected value from the merger.